Clover Health Reports Improved Q1 2024 Financial Results and FY 2024 Guidance
DENVER, Colo., May 08, 2024 (247marketnews.com)- Clover Health Investments, Corp. (NASDAQ:CLOV) reported its first quarter 2024 financial results.
Clover’s financial results for the first quarter exceeded its expectations, including total revenue of $346.9 million and GAAP net loss from continuing operations improving from a loss of $79.7 million, for the first quarter of 2023, to a loss of $23.2 million, and adjusted EBITDA improved to a profit of $6.8 million, as compared to the prior year period loss of $37.5 million.
Clover is now projecting improved 2024 guidance, with insurance revenue of $1.30-$1.35 billion and adjusted EBITDA profitability of $10-$30 million
Andrew Toy, Clover Health’s CEO, commented, “I am incredibly proud of our results this quarter for several notable reasons. First, Clover was profitable on an Adjusted EBITDA basis for the first quarter, and we have high confidence in achieving full year 2024 Adjusted EBITDA profitability. Second, we have grown revenues in our Insurance business by 8% year-over-year. Based on these results, we are delighted to improve our full-year 2024 guidance. In addition, we are pleased to announce that our Board of Directors has authorized a share repurchase program of up to $20 million dollars of the Company’s Class A Common Stock over the next two years,” said Clover Health CEO Andrew Toy.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (CLOV)
- PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
- Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
- Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
- Clover Health Exits ACO REACH to Accelerate Path to Profitability